First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations

Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations t...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic pathology Vol. 7; no. 1; p. 93
Main Authors: Elmahmoudi, Hejer, Khodjet-el-khil, Houssein, Wigren, Edvard, Jlizi, Asma, Zahra, Kaouther, Pellechia, Dorothé, Vinciguerra, Christine, Meddeb, Balkis, Elggaaied, Amel Ben Ammar, Gouider, Emna
Format: Journal Article
Language:English
Published: England BioMed Central Ltd 10-08-2012
BioMed Central
BMC
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder. In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum. We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure. We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles. The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features. The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/1693269827490715.
AbstractList Doc number: 93 Abstract Introduction: Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder. Aim: In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum. Methods: We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure. Results: We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles. Conclusion: The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features. Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1693269827490715
Introduction Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder. Aim In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum. Methods We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure. Results We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles. Conclusion The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features. Virtual slides The virtual slide(s) for this article can be found here: Keywords: Hemophilia A, Mutations, Intron 22 inversion, Intron 1 inversion, Inhibitors, Molecular analysis, Tunisia
INTRODUCTION: Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder. AIM: In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum. METHODS: We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure. RESULTS: We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles. CONCLUSION: The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/1693269827490715
Abstract Introduction Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder. Aim In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum. Methods We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure. Results We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles. Conclusion The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features. Virtual slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1693269827490715
Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder. In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum. We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure. We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles. The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features.
Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder. In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum. We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure. We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles. The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features. The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/1693269827490715.
ArticleNumber 93
Audience Academic
Author Gouider, Emna
Elmahmoudi, Hejer
Meddeb, Balkis
Elggaaied, Amel Ben Ammar
Wigren, Edvard
Khodjet-el-khil, Houssein
Zahra, Kaouther
Jlizi, Asma
Pellechia, Dorothé
Vinciguerra, Christine
AuthorAffiliation 4 Biological hematology department EAM 4174, Hospices Civils de Lyon Université de Lyon, Lyon, France
3 Hemophilia Treatment Center, Aziza Othmana Hospital, Tunis, Tunisia
2 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
1 Laboratory of Genetics, Immunology and Human Pathologies, Tunis, Tunisia
AuthorAffiliation_xml – name: 2 Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
– name: 1 Laboratory of Genetics, Immunology and Human Pathologies, Tunis, Tunisia
– name: 3 Hemophilia Treatment Center, Aziza Othmana Hospital, Tunis, Tunisia
– name: 4 Biological hematology department EAM 4174, Hospices Civils de Lyon Université de Lyon, Lyon, France
Author_xml – sequence: 1
  givenname: Hejer
  surname: Elmahmoudi
  fullname: Elmahmoudi, Hejer
  email: hejer.abdalah@gmail.com
  organization: Laboratory of Genetics, Immunology and Human Pathologies, Tunis, Tunisia. hejer.abdalah@gmail.com
– sequence: 2
  givenname: Houssein
  surname: Khodjet-el-khil
  fullname: Khodjet-el-khil, Houssein
– sequence: 3
  givenname: Edvard
  surname: Wigren
  fullname: Wigren, Edvard
– sequence: 4
  givenname: Asma
  surname: Jlizi
  fullname: Jlizi, Asma
– sequence: 5
  givenname: Kaouther
  surname: Zahra
  fullname: Zahra, Kaouther
– sequence: 6
  givenname: Dorothé
  surname: Pellechia
  fullname: Pellechia, Dorothé
– sequence: 7
  givenname: Christine
  surname: Vinciguerra
  fullname: Vinciguerra, Christine
– sequence: 8
  givenname: Balkis
  surname: Meddeb
  fullname: Meddeb, Balkis
– sequence: 9
  givenname: Amel Ben Ammar
  surname: Elggaaied
  fullname: Elggaaied, Amel Ben Ammar
– sequence: 10
  givenname: Emna
  surname: Gouider
  fullname: Gouider, Emna
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22883072$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:125506239$$DView record from Swedish Publication Index
BookMark eNp1kstr3DAQxk1JaR7ttcdi6NmJHtarh8ISmjYQ6CU9C1mPXW1taSvZG_rfV85uN1maIoTEN9_8GGbmvDoJMdiqeg_BJYScXkHW0gYSQRvWCPyqOjsIJ8_-p9V5zmsAWkIQeFOdIsQ5BgydVcONT3msk93ENNbR1UPsrZ56lWrj1TLE7PMs30_BZ69CvbJD3Kx875XO9eJT7Y0No3deq9HHMFt5HeLW9rVWUy7i1tbDND5G89vqtVN9tu_270X14-bL_fW35u7719vrxV3TUcHGxhIFINAUISAwZUQwTLSzXAiNW8047UTXEdYi1hGgUUchd8Y5YwBCVmuBL6rbHddEtZab5AeVfsuovHwUYlpKlUaveysFJ4g4p4izuuUacGi6rsXUUKAVBaCwxI6VH-xm6o5omxSN3Os__XxlthIiQgBFeK7j8y63GAZrdGlVUv0x4igS_Eou41biljMmaAEsdoDOx_8AjiM6DnIeu5zHLpkUuDA-7otI8ddk8yjXcUqh9F9CiFohICPwybVUpSs-uFh4evBZywXBLUZQIF5cly-4yjF28LqspvNFfylBp5hzsu5QOwRy3uB_q_3wvGUH-9-VxX8AGgzvRA
CitedBy_id crossref_primary_10_51847_YerIDDpIcm
crossref_primary_10_1186_1746_1596_8_78
crossref_primary_10_1177_1076029613513321
crossref_primary_10_1111_hae_13207
crossref_primary_10_1155_2020_3428648
crossref_primary_10_7759_cureus_28247
crossref_primary_10_3390_genes12111820
crossref_primary_10_1080_16078454_2018_1560934
crossref_primary_10_1097_MBC_0000000000000653
Cites_doi 10.1182/blood-2006-06-026104
10.1111/j.1538-7836.2008.03256.x
10.3378/1534-6617-80.4.435
10.1182/blood.V86.6.2206.bloodjournal8662206
10.1111/j.1538-7836.2006.01840.x
10.1002/humu.20208
10.1111/j.1365-2141.2005.05737.x
10.1002/humu.10056
10.1038/nrg1617
10.1007/s00277-010-1115-x
10.1111/j.1365-2516.2008.01690.x
10.1046/j.1365-2141.1998.01122.x
10.1182/blood.V88.4.1183.bloodjournal8841183
10.1182/blood.V99.1.168
10.1186/1746-1596-6-54
10.1111/j.1365-2516.2009.02081.x
10.1055/s-0037-1619754
10.1097/MBC.0b013e328329e456
10.1046/j.1538-7836.2003.00149.x
10.1002/1098-1004(200012)16:6<530::AID-HUMU16>3.0.CO;2-3
10.1046/j.1365-2141.2001.03173.x
10.1074/jbc.M710252200
10.1182/blood-2011-09-379453
10.1111/j.1365-2516.2010.02420.x
10.1002/ajh.20865
10.1046/j.1365-2516.2000.00365.x
ContentType Journal Article
Copyright COPYRIGHT 2012 BioMed Central Ltd.
2012 Elmahmoudi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ©2012 Elmahmoudi et al.; licensee BioMed Central Ltd. 2012 Elmahmoudi et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2012 BioMed Central Ltd.
– notice: 2012 Elmahmoudi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright ©2012 Elmahmoudi et al.; licensee BioMed Central Ltd. 2012 Elmahmoudi et al.; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
K9.
M0S
M1P
M7Z
P64
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
ADTPV
AOWAS
D8T
ZZAVC
DOA
DOI 10.1186/1746-1596-7-93
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database (Proquest) (PQ_SDU_P3)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Technology Research Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Biochemistry Abstracts 1
Engineering Research Database
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database




MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1746-1596
EndPage 93
ExternalDocumentID oai_doaj_org_article_98525ffa5fec48c081dbb436d60ca600
oai_prod_swepub_kib_ki_se_125506239
oai_biomedcentral_com_1746_1596_7_93
2803859701
A534321928
10_1186_1746_1596_7_93
22883072
Genre Journal Article
GeographicLocations Tunisia
GeographicLocations_xml – name: Tunisia
GroupedDBID ---
-A0
0R~
29G
2VQ
2WC
3V.
4.4
53G
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFS
ACIHN
ACIWK
ACPRK
ACRMQ
ADBBV
ADINQ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBD
EBLON
EBS
ECM
EIF
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M~E
NPM
O5R
O5S
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
~8M
AAYXX
CITATION
7XB
8FD
8FK
AZQEC
DWQXO
FR3
K9.
M7Z
P64
PQEST
PQUKI
PRINS
ABVAZ
AFGXO
AFNRJ
5PM
ADTPV
AOWAS
C1A
D8T
H13
ZZAVC
ID FETCH-LOGICAL-b697t-e5a010c6220936759735cfe899c34c786b9bb57427b50c2b618fdffdd022ecc93
IEDL.DBID RPM
ISSN 1746-1596
IngestDate Tue Oct 22 15:07:50 EDT 2024
Wed Oct 30 05:05:35 EDT 2024
Tue Sep 17 21:08:23 EDT 2024
Wed May 22 07:15:14 EDT 2024
Thu Oct 10 22:44:37 EDT 2024
Tue Nov 19 21:30:56 EST 2024
Tue Nov 12 23:35:15 EST 2024
Thu Sep 12 19:51:35 EDT 2024
Sat Sep 28 07:51:37 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b697t-e5a010c6220936759735cfe899c34c786b9bb57427b50c2b618fdffdd022ecc93
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487796/
PMID 22883072
PQID 1124991751
PQPubID 54778
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_98525ffa5fec48c081dbb436d60ca600
swepub_primary_oai_prod_swepub_kib_ki_se_125506239
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3487796
biomedcentral_primary_oai_biomedcentral_com_1746_1596_7_93
proquest_journals_1124991751
gale_infotracmisc_A534321928
gale_infotracacademiconefile_A534321928
crossref_primary_10_1186_1746_1596_7_93
pubmed_primary_22883072
PublicationCentury 2000
PublicationDate 2012-08-10
PublicationDateYYYYMMDD 2012-08-10
PublicationDate_xml – month: 08
  year: 2012
  text: 2012-08-10
  day: 10
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Diagnostic pathology
PublicationTitleAlternate Diagn Pathol
PublicationYear 2012
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 19317598 - Hum Biol. 2008 Aug;80(4):435-48
16173970 - Br J Haematol. 2005 Oct;131(1):109-17
16460442 - J Thromb Haemost. 2006 Mar;4(3):591-8
22282501 - Blood. 2012 Mar 22;119(12):2922-34
21072517 - Ann Hematol. 2011 May;90(5):579-84
19067791 - J Thromb Haemost. 2009 Mar;7(3):438-44
21070499 - Haemophilia. 2011 Mar;17(2):275-81
22057311 - Hamostaseologie. 2011 Nov;31 Suppl 1:S69-73
11102988 - Hum Mutat. 2000 Dec;16(6):530-1
12857556 - Haematologica. 2003 Jul;88(7):778-84
19817879 - Haemophilia. 2010 Jan;16(1):136-42
10632737 - Haemophilia. 2000 Jan;6(1):21-2
17211847 - Am J Hematol. 2007 Apr;82(4):283-7
17209060 - Blood. 2007 May 1;109(9):3713-24
8695835 - Blood. 1996 Aug 15;88(4):1183-7
7662970 - Blood. 1995 Sep 15;86(6):2206-12
11857744 - Hum Mutat. 2002 Mar;19(3):274-8
21682900 - Diagn Pathol. 2011;6:54
21052611 - Hamostaseologie. 2010 Nov;30 Suppl 1:S150-2
19267246 - Breast Cancer Res Treat. 2010 Feb;119(3):547-50
9886318 - Br J Haematol. 1998 Dec;103(4):1051-60
18299331 - J Biol Chem. 2008 Apr 25;283(17):11645-51
16086318 - Hum Mutat. 2005 Sep;26(3):249-54
12871415 - J Thromb Haemost. 2003 Apr;1(4):773-81
11843836 - Br J Haematol. 2001 Dec;115(4):977-82
11756167 - Blood. 2002 Jan 1;99(1):168-74
15931172 - Nat Rev Genet. 2005 Jun;6(6):488-501
18371166 - Haemophilia. 2008 May;14(3):484-8
19448530 - Blood Coagul Fibrinolysis. 2009 Sep;20(6):415-8
SC Gouw (591_CR25) 2011; 17
N Bogdanova (591_CR19) 2005; 26
H Wakabayashi (591_CR30) 2009; 7
S Nakaya (591_CR18) 2001; 115
D Habart (591_CR28) 2003; 1
J Boekhorst (591_CR23) 2005; 131
RD Bagnall (591_CR7) 2002; 99
A Awidi (591_CR13) 2010; 16
K Abu-Amero (591_CR11) 2008; 14
SE Antonarakis (591_CR3) 1995; 86
E Hejer (591_CR5) 2011; 6
L Salazar-Sánchez (591_CR10) 2010; 30
H Andrikovics (591_CR16) 2003; 88
TM Owaidah (591_CR12) 2009; 20
SC Gouw (591_CR24) 2012; 119
M Liu (591_CR31) 1998; 103
S Nakaya (591_CR26) 2001; 115
JA Cutler (591_CR20) 2002; 19
J Graw (591_CR1) 2005; 6
WL DeLano (591_CR8) 2002
De Brasi (591_CR17) 2000; 6
VO Thomas (591_CR21) 2010; 19
RD Bagnall (591_CR6) 2006; 4
MA Zimmermann (591_CR2) 2011; 31
H Khodjet-El-Khil (591_CR15) 2008; 80
JM Mantilla-Capacho (591_CR9) 2007; 82
SC Gouw (591_CR4) 2011; 17
H Wakabayashi (591_CR29) 2008; 283
V Akkarepatumwong (591_CR27) 2000; 16
KR Viel (591_CR22) 2007; 109
H Abou-Elew (591_CR14) 2011; 90
WC Nichols (591_CR32) 1996; 15
References_xml – volume: 109
  start-page: 3713
  year: 2007
  ident: 591_CR22
  publication-title: Blood
  doi: 10.1182/blood-2006-06-026104
  contributor:
    fullname: KR Viel
– volume: 7
  start-page: 438
  year: 2009
  ident: 591_CR30
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2008.03256.x
  contributor:
    fullname: H Wakabayashi
– volume: 30
  start-page: 1150
  year: 2010
  ident: 591_CR10
  publication-title: Hämostaseologie
  contributor:
    fullname: L Salazar-Sánchez
– volume: 80
  start-page: 435
  year: 2008
  ident: 591_CR15
  publication-title: Hum Biol
  doi: 10.3378/1534-6617-80.4.435
  contributor:
    fullname: H Khodjet-El-Khil
– volume: 86
  start-page: 2206
  year: 1995
  ident: 591_CR3
  publication-title: Blood
  doi: 10.1182/blood.V86.6.2206.bloodjournal8662206
  contributor:
    fullname: SE Antonarakis
– volume: 4
  start-page: 591
  year: 2006
  ident: 591_CR6
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2006.01840.x
  contributor:
    fullname: RD Bagnall
– volume: 26
  start-page: 249
  year: 2005
  ident: 591_CR19
  publication-title: Hum Mutat
  doi: 10.1002/humu.20208
  contributor:
    fullname: N Bogdanova
– volume: 131
  start-page: 109
  year: 2005
  ident: 591_CR23
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2005.05737.x
  contributor:
    fullname: J Boekhorst
– volume: 19
  start-page: 274
  year: 2002
  ident: 591_CR20
  publication-title: Hum Mutat
  doi: 10.1002/humu.10056
  contributor:
    fullname: JA Cutler
– volume: 6
  start-page: 488
  year: 2005
  ident: 591_CR1
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg1617
  contributor:
    fullname: J Graw
– volume: 90
  start-page: 579
  year: 2011
  ident: 591_CR14
  publication-title: Ann Hematol
  doi: 10.1007/s00277-010-1115-x
  contributor:
    fullname: H Abou-Elew
– volume: 14
  start-page: 484
  year: 2008
  ident: 591_CR11
  publication-title: Haemophilia
  doi: 10.1111/j.1365-2516.2008.01690.x
  contributor:
    fullname: K Abu-Amero
– volume: 103
  start-page: 1051
  year: 1998
  ident: 591_CR31
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.1998.01122.x
  contributor:
    fullname: M Liu
– volume: 15
  start-page: 1183
  year: 1996
  ident: 591_CR32
  publication-title: Blood
  doi: 10.1182/blood.V88.4.1183.bloodjournal8841183
  contributor:
    fullname: WC Nichols
– volume: 99
  start-page: 168
  year: 2002
  ident: 591_CR7
  publication-title: Blood
  doi: 10.1182/blood.V99.1.168
  contributor:
    fullname: RD Bagnall
– volume: 6
  start-page: 54
  year: 2011
  ident: 591_CR5
  publication-title: Diagn Pathol
  doi: 10.1186/1746-1596-6-54
  contributor:
    fullname: E Hejer
– volume: 16
  start-page: 136
  year: 2010
  ident: 591_CR13
  publication-title: Haemophilia
  doi: 10.1111/j.1365-2516.2009.02081.x
  contributor:
    fullname: A Awidi
– volume: 31
  start-page: 69
  year: 2011
  ident: 591_CR2
  publication-title: Hamostaseologie
  doi: 10.1055/s-0037-1619754
  contributor:
    fullname: MA Zimmermann
– volume: 88
  start-page: 778
  year: 2003
  ident: 591_CR16
  publication-title: Haematologica
  contributor:
    fullname: H Andrikovics
– volume: 20
  start-page: 415
  year: 2009
  ident: 591_CR12
  publication-title: Blood Coagul Fibrinolysis
  doi: 10.1097/MBC.0b013e328329e456
  contributor:
    fullname: TM Owaidah
– volume: 1
  start-page: 773
  year: 2003
  ident: 591_CR28
  publication-title: J Thromb Haemost
  doi: 10.1046/j.1538-7836.2003.00149.x
  contributor:
    fullname: D Habart
– volume: 16
  start-page: 530
  year: 2000
  ident: 591_CR27
  publication-title: Hum Mutat
  doi: 10.1002/1098-1004(200012)16:6<530::AID-HUMU16>3.0.CO;2-3
  contributor:
    fullname: V Akkarepatumwong
– volume: 115
  start-page: 977
  year: 2001
  ident: 591_CR18
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2001.03173.x
  contributor:
    fullname: S Nakaya
– volume: 115
  start-page: 977
  year: 2001
  ident: 591_CR26
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.2001.03173.x
  contributor:
    fullname: S Nakaya
– volume: 19
  start-page: 547
  year: 2010
  ident: 591_CR21
  publication-title: Breast Cancer Research and Treatment
  contributor:
    fullname: VO Thomas
– volume-title: The PyMOL Molecular Graphics System
  year: 2002
  ident: 591_CR8
  contributor:
    fullname: WL DeLano
– volume: 283
  start-page: 11645
  year: 2008
  ident: 591_CR29
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M710252200
  contributor:
    fullname: H Wakabayashi
– volume: 119
  start-page: 2922
  year: 2012
  ident: 591_CR24
  publication-title: Blood
  doi: 10.1182/blood-2011-09-379453
  contributor:
    fullname: SC Gouw
– volume: 17
  start-page: 275
  year: 2011
  ident: 591_CR4
  publication-title: Haemophilia
  doi: 10.1111/j.1365-2516.2010.02420.x
  contributor:
    fullname: SC Gouw
– volume: 17
  start-page: 275
  year: 2011
  ident: 591_CR25
  publication-title: Haemophilia
  doi: 10.1111/j.1365-2516.2010.02420.x
  contributor:
    fullname: SC Gouw
– volume: 82
  start-page: 283
  year: 2007
  ident: 591_CR9
  publication-title: Am J Hematol
  doi: 10.1002/ajh.20865
  contributor:
    fullname: JM Mantilla-Capacho
– volume: 6
  start-page: 21
  year: 2000
  ident: 591_CR17
  publication-title: Haemophilia
  doi: 10.1046/j.1365-2516.2000.00365.x
  contributor:
    fullname: De Brasi
SSID ssj0045520
Score 2.0067787
Snippet Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of...
Introduction Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative...
Doc number: 93 Abstract Introduction: Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative...
INTRODUCTION: Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative...
Abstract Introduction Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or...
SourceID doaj
swepub
pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 93
SubjectTerms Adolescent
Adult
Analysis
Blood coagulation factor VIII
Blotting, Southern
Child
Child, Preschool
Computational Biology
Databases, Genetic
DNA Mutational Analysis
Exons
Factor VIII - chemistry
Factor VIII - genetics
Gene mutations
Genes
Genetic aspects
Genetic Predisposition to Disease
Hemophilia
Hemophilia A
Hemophilia A - blood
Hemophilia A - diagnosis
Hemophilia A - genetics
Humans
Inhibitors
Intron 1 inversion
Intron 22 inversion
Introns
Medicin och hälsovetenskap
Models, Molecular
Molecular analysis
Mutagenesis, Insertional
Mutation
Mutation, Missense
Mutations
Phenotype
Point Mutation
Polymerase Chain Reaction
Protein Conformation
Sequence Deletion
Sequence Inversion
Severity of Illness Index
Structure-Activity Relationship
Tunisia
Tunisia - epidemiology
Young Adult
SummonAdditionalLinks – databaseName: BiomedCentral
  dbid: RBZ
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLZouXBhEVugIB-Q4GKReHdvU-ioJw5QJMTF8qqO6GQq0uH385xkKtzhgMQhFy-JnffZ_l6c9xmhN1wGQ2N0hAehCTcxEKc9I0Z3WUTuoxiDws6-qE_f9MfTIpPz7u87-J2W74EySwKLriSKGHaA7oLDwAuWP5983825XAg6hz5OZWd5xv36t-LaL6vlaFTt35-b_1icbv84WcmLjkvS8sG_d-Yhuj_TTryYcPII3Un9Y7ReroD74WnbAG8yXu_OysVx-gNvNZTk87LlDTDCF2m9uSpfYFwY8OIYT1G-ef7sV4pq3G9-pUsc3HYYJcXxejtt9g9P0Nfl6fmHMzIfv0C8NOqaJOHAWQuS0tYw8CuMYiLkBA5aYDwoLb3xXoBrrbxoA_Wy0znmHCPQAgCGYU_RYb_p03OETey0Ui4or8Ad9AqAEBMTnjqnc0q-QceVVezVJLVhi_h1nQPj0Ja3aMtbtMoa1qC3OxPe1BtdGy33Sp4UC1d3HxPARHYeqdZoQUXOTuQUuA5AmaL3nMko2-CAHsLjCj5smQCgRcHNcQzQ0yKlZReixOoCcdYNOqpKwsANdfYOYXaeOAZoNcAbXGjRNejZBLab5tJyMnSraINUBcOqP3VOv7oYJcMZ-KXKyAbRCbB1FViq7Zz-Y1UuOyQLzFe0QI7Ni_8xzkt0DygmJaOI8BE6vP65Ta_QwRC3r8cR_BtoHkPi
  priority: 500
  providerName: BioMedCentral
– databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07bxQxELYgFQ0C8VoIyAUSlZVd7_qV7oCcUtEQJDrLT-VEbi9ic_x-xo87YVLQUGxje3dtz9gzn-35jND7iTtFvTdkckySSXlHjLQjUXKIzE_WsxwUdvlVfPkuP18kmpzjVV_pTFihBy4dd6YkoyxGw2Jwk3Rgwby108g9750Ba51n354fwFSZgyfGaA2F5AQMNq90jYPkZ8c0Ikjabm7i3G8a85RZ_O_P1X8Yq78PUjZ0o9lErZ-gx9W3xKvSpqfoQZifoe16Aw4eLnsDeBfx9nAhLvblmN1mSclXaV8bdAVfh-3uNi2zGLfg1Tkuobyxru2lohLPu1_hBjuzXzJvON7uy47-8hx9W19cfbok9Y4FYrkSdyQwA4jMcUp7NQJ4UGJkLgZAYW6cnJDcKmsZ4GdhWe-o5YOMPkbvwfaD9NX4Ap3Muzm8Qlj5QQphnLACMJ8VIG0fRmapMTKGYDt03nS1vi18GjoxXLc5MNh0kpNOctJCq7FDHw5yOb6X8Yvk90p-TGJrvp4TQKt01Sr9L62C3yWh6zTKoUbO1GAFaGniy9IrlgJywTuWHTptSsLodG32QW10nR0WqDWAXsDJbOjQy6JBx-rSdP1zL2iHRKNbTXvanHlznXnBRwCfQvEO0aKF7Stgj3VN_7FJj16CBveW9eABq9f_o9feoEfgT1KSGYNP0cndz314ix4ufv8uD8_fN2dBdg
  priority: 102
  providerName: Directory of Open Access Journals
Title First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations
URI https://www.ncbi.nlm.nih.gov/pubmed/22883072
https://www.proquest.com/docview/1124991751
http://dx.doi.org/10.1186/1746-1596-7-93
https://pubmed.ncbi.nlm.nih.gov/PMC3487796
http://kipublications.ki.se/Default.aspx?queryparsed=id:125506239
https://doaj.org/article/98525ffa5fec48c081dbb436d60ca600
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYnrggEK_QUvmAxMndbBK_etuWrnoBISgS4mL5SVdssqumy-9n7CRV3d44ZA-2kzg7M55vbM9nhD40zMrKOU0aSwVppLNEC1MTKRaBusY4mpLCLr_zLz_Fp4tIk0OnXJi0ad-a9Um3aU-69XXaW7lr7XzaJzb_-vm8BpTNJZvP0Ayw4RSiD8NvQ2lVjuyMC8HmgLgZAZ_NCCcynppTxfN1y8gInGW4bzLHlPj7H4_S99zUwy2UGdFock6r5-jZiCrxcuj9C_TEdy9Ru1oDtMPDqgDeBtxOR-FiN2ywW_ex-CquaIOW4GvfbndxgkXbHi9P8ZDEG8ZZvdhU4G7712-w1fs-MYbjdj-s5fev0I_VxdX5JRlPVyCGSX5LPNUQi1lWVaWsIWyQvKY2eIi_bN1YLpiRxlCInLmhpa0MW4jgQnAOvD7IXdav0UG37fxbhKVbgEC05YZDtGc4yNn5mppKaxG8NwU6zf5qtRuYNFTkts5rwMxUFJmKIlNcybpAHye53N2XIhfBHrU8i2LLnp4Ktje_1ag_Sgpa0RA0Dd42wgIicsY0NXOstBrQH7wuCl1F-4YeWT2mKcCXRqYstaQxFRdwsSjQUdYS7NLm1ZPaqHFc6KHXEO5ChEwXBXozaNBddyfFLBDPdCv7nrwGDCQxgo8GUaBq0ML8FvDEaiz_s46X6r0CYEtLwL7y3X-_7hA9BfhYkUQQfIQObm_2_j2a9W5_nKY24Pfb2a_jZJ7_AAT0Qbs
link.rule.ids 108,230,315,729,782,786,866,887,2106,24946,27933,27934,53800,53802,75821,75822
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoOcCFh3ilFPABiVO62SR-9baUrhbRVkgsEjfLT7pik1013f5-xk5SYXrrIRfbSWzNZ_ubZOYzQh9rakRprcprQ3heC2tyxXWVCz71xNbakpgUtvjBLn7xL6dBJoeMuTAxaN_o1VG7bo7a1WWMrdw2ZjLGiU2-n59UwLKZoJM99BDma1GMTnq_ANeElMWgzzjldAKcm-awa9Oc5SKcm1OGE3aLoAmc5Livk60pKvjfXaf_2aj-D6JMpEbj9jR_es-BPUNPBj6KZ331c_TAtS9QM18BKcT9_wS88bgZD9HFtg_NW3WheBn-hQO-8KVrNtvwaUaZDs-OcZ_-64fvgaEpx-3mxq2xUbsuao3jZtdHAXQv0c_56fJkkQ_nMuSaCnadO6LAizO0LAtRgcMhWEWMd-C5mao2jFMttCbgczNNClNqOuXeem8t8AVAjKheof1207o3CAs7hRErwzQDP1EzQIh1FdGlUtw7pzN0nJhIbnsNDhlUsdMamKAymFoGU0smRZWhT6M9b--LPg-nd1p-DuZOnh4LNle_5WAgKTgpifeKeGdqboBLWa3rilpaGAW8EV4XwCLDygA9MmpIcICRBo0tOSMhiRcYNc_QYdISZrRJq0e4yWFF6aDX4CiDb02mGXrdI--2uyOgM8QSTCbjSWsAgVFLfEBchsoevektsIfLofzPKlyycxIoMSmANYuDe7_uA3q0WJ6fybOvF9_eosdAQss8ygwfov3rq517h_Y6u3sfp_VfqiNVSw
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZokRAXHuIVKOADEid3s0n86m1puyoCqkoUiZsVv2jEJrtquvx-xk6ywvQGh1xsJ7E1n-1vkpnPCL2rmJGFtTWpDBWkktaQWuiSSDH31Fba0pgUdvaVn38XJ6dBJmd31FcM2je6OexW7WHXXMXYyk1rZlOc2Oziy3EJLJtLNttYP9tDd2HO5sXkqA-LcEVpkY8ajXPBZsC7GYGdmxFOZDg7pwin7OZBFzjJc18l21NU8b-9Vv-xWf0dSJnIjcYtavnwPwb3CD0YeSleDE0eozuue4LaZQPkEA__FfDa43Y6TBfbIUSv6UPxZfgnDjjDV65db8Inmtr0eHGEhzRgP34XDE0F7ta_3AqbettHzXHcbodogP4p-rY8vTw-I-P5DEQzyW-IozV4c4YVRS5LcDwkL6nxDjw4U1aGC6al1hR8b65pbgrN5sJb760F3gDIkeUztN-tO_cCYWnnMOracM3BX9QckGJdSXVR18I7pzN0lJhJbQYtDhXUsdMamKgqmFsFcyuuZJmh95NNd_dF30ewWy0_BJMnT48F6-sfajSSkoIW1PuaemcqYYBTWa2rklmWmxr4I7wuAEaFFQJ6ZOox0QFGGrS21IKGZF5g1iJDB0lLmNkmrZ4gp8aVpYdeg8MMPjadZ-j5gL5ddydQZ4gnuEzGk9YACqOm-Ii6DBUDgtNbYC9XY_nPJlyqdwqoMc2BPcuX__y6t-jexclSff54_ukVug9ctCBRbfgA7d9cb91rtNfb7Zs4s38DItpXyw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=First+report+of+molecular+diagnosis+of+Tunisian+hemophiliacs+A%3A+Identification+of+8+novel+causative+mutations&rft.jtitle=Diagnostic+pathology&rft.au=Elmahmoudi%2C+Hejer&rft.au=Khodjet-el-khil%2C+Houssein&rft.au=Wigren%2C+Edvard&rft.au=Jlizi%2C+Asma&rft.date=2012-08-10&rft.pub=BioMed+Central&rft.eissn=1746-1596&rft.volume=7&rft_id=info:doi/10.1186%2F1746-1596-7-93&rft.externalDocID=2803859701
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1746-1596&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1746-1596&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1746-1596&client=summon